Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 2/20 | 0.70 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.70 |
| ▸ | DNPH1 | O43598 | 5/20 | 0.69 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.69 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.67 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.67 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.67 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.67 |
| ▸ | LDHA | P00338 | 1/20 | 0.67 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.67 |
| ▸ | FBP1 | P09467 | 1/20 | 0.67 |
| ▸ | SRC | P12931 | 1/20 | 0.67 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.67 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.67 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.67 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.67 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.67 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4820076 | 0.99 | P2RX3 (0.71) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL20705924 | 0.96 | P2RX3 (0.72) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL25698378 | 0.96 | P2RX3 (0.72) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL4820592 | 0.93 | DNPH1 (0.73) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL4217929 | 0.93 | P2RX3 (0.82) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL30853828 | 0.93 | P2RX3 (0.82) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL8738522 | 0.93 | P2RX3 (0.82) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL15305350 | 0.93 | P2RX3 (0.67) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL14946186 | 0.92 | TAS1R3 (0.65) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 | |
| SCHEMBL216009 | 0.92 | P2RX3 (0.60) | P2RX3P2RX2DNPH1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040241649-A1 | RNA CONTAINING COENZYMES, BIOTIN, OR FLUOROPHORES, AND METHODS FOR THEIR PREPARATION AND USE | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2004-12-02 | — | — | US | claimed |
| US-20260055151-A1 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | LUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER (US) | 2026-02-26 | — | — | US | disclosed |
| US-20230192792-A1 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | LUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230055379-A1 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | LUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER (US) | 2023-02-23 | — | — | US | disclosed |
| US-8088897-B2 | Detecting the activity of and screening acceptor substrates, inhibitors, or activators of enzymes catalyzing group transfer reactions to facilitate the development of more selective and therapeutic drugs | BellBrook Labs, Inc. (US) | 2012-01-03 | — | — | US | disclosed |
| US-7579162-B2 | Method of detection in homogeneous phase, especially of progesterone in mammals' milk, and corresponding kit | CEVA SANTE ANIMALE (FR) | 2009-08-25 | — | — | US | disclosed |
| US-20080269217-A1 | Melanocortin-4 receptor binding compounds and methods of use thereof | ORE PHARMACEUTICALS, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| US-20080233592-A1 | Assay Method for Group Transfer Reactions | BELLBROOK LABS, LLC | 2008-09-25 | — | — | US | disclosed |
| US-7378505-B2 | Assay method for group transfer reactions | BELLBROOK LABS LLC (US) | 2008-05-27 | — | — | US | disclosed |
| US-7375125-B2 | Melanocortin-4 receptor binding compounds and methods of use thereof | ORE PHARMACEUTICALS, INC. (US) | 2008-05-20 | — | — | US | disclosed |
| EP-1915619-A2 | METHOD FOR CARRYING OUT HOMOGENEOUS PHASE DETECTION, IN PARTICULAR, FOR DETECTING THE PROGESTERONE IN THE MILK OF A MAMMAL AND CORRESPONDING KIT | CEVA SANTE ANIMALE (FR) | 2008-04-30 | — | — | EP | disclosed |
| US-7323319-B2 | RNA containing coenzymes, biotin, or fluorophores, and methods for their preparation and use | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2008-01-29 | — | — | US | disclosed |
| WO-2007020357-A2 | METHOD FOR CARRYING OUT HOMOGENEOUS PHASE DETECTION, IN PARTICULAR, FOR DETECTING THE PROGESTERONE IN THE MILK OF A MAMMAL AND CORRESPONDING KIT | CEVA SANTE ANIMALE (FR) | 2007-02-22 | — | — | WO | disclosed |
| US-20070042449-A1 | Method of detection in homogeneous phase, especially of progesterone in mammals' milk, and corresponding kit | CEVA SANTE ANIMALE (FR) | 2007-02-22 | — | — | US | disclosed |
| US-20060172335-A1 | Assay method for group transfer reactions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-08-03 | — | — | US | disclosed |
| US-20040241649-A1 | RNA CONTAINING COENZYMES, BIOTIN, OR FLUOROPHORES, AND METHODS FOR THEIR PREPARATION AND USE | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055151-A1 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | CCL5, PRKCZ, VIP | P2RX3 945/4885P2RX2 1411/4885DNPH1 4607/4885 |
| US-20080269217-A1 | Melanocortin-4 receptor binding compounds and methods of use thereof | MC4R, MC5R, MC3R | P2RX3 344/4885P2RX2 262/4885DNPH1 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.